Cargando…
2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2
Two-dimensional transition metal carbides/carbonitrides known as MXenes are rapidly growing as multimodal nanoplatforms in biomedicine. Here, taking SARS-CoV-2 as a model, we explored the antiviral properties and immune-profile of a large panel of four highly stable and well-characterized MXenes - T...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969865/ https://www.ncbi.nlm.nih.gov/pubmed/33753982 http://dx.doi.org/10.1016/j.nantod.2021.101136 |
_version_ | 1783666316345868288 |
---|---|
author | Unal, Mehmet Altay Bayrakdar, Fatma Fusco, Laura Besbinar, Omur Shuck, Christopher E. Yalcin, Süleyman Erken, Mine Turktas Ozkul, Aykut Gurcan, Cansu Panatli, Oguzhan Summak, Gokce Yagmur Gokce, Cemile Orecchioni, Marco Gazzi, Arianna Vitale, Flavia Somers, Julia Demir, Emek Yildiz, Serap Suzuk Nazir, Hasan Grivel, Jean-Charles Bedognetti, Davide Crisanti, Andrea Akcali, Kamil Can Gogotsi, Yury Delogu, Lucia Gemma Yilmazer, Açelya |
author_facet | Unal, Mehmet Altay Bayrakdar, Fatma Fusco, Laura Besbinar, Omur Shuck, Christopher E. Yalcin, Süleyman Erken, Mine Turktas Ozkul, Aykut Gurcan, Cansu Panatli, Oguzhan Summak, Gokce Yagmur Gokce, Cemile Orecchioni, Marco Gazzi, Arianna Vitale, Flavia Somers, Julia Demir, Emek Yildiz, Serap Suzuk Nazir, Hasan Grivel, Jean-Charles Bedognetti, Davide Crisanti, Andrea Akcali, Kamil Can Gogotsi, Yury Delogu, Lucia Gemma Yilmazer, Açelya |
author_sort | Unal, Mehmet Altay |
collection | PubMed |
description | Two-dimensional transition metal carbides/carbonitrides known as MXenes are rapidly growing as multimodal nanoplatforms in biomedicine. Here, taking SARS-CoV-2 as a model, we explored the antiviral properties and immune-profile of a large panel of four highly stable and well-characterized MXenes - Ti(3)C(2)T(x), Ta(4)C(3)T(x), Mo(2)Ti(2)C(3)T(x) and Nb(4)C(3)T(x). To start with antiviral assessment, we first selected and deeply analyzed four different SARS-CoV-2 genotypes, common in most countries and carrying the wild type or mutated spike protein. When inhibition of the viral infection was tested in vitro with four viral clades, Ti(3)C(2)T(x) in particular, was able to significantly reduce infection only in SARS-CoV-2/clade GR infected Vero E6 cells. This difference in the antiviral activity, among the four viral particles tested, highlights the importance of considering the viral genotypes and mutations while testing antiviral activity of potential drugs and nanomaterials. Among the other MXenes tested, Mo(2)Ti(2)C(3)T(x) also showed antiviral properties. Proteomic, functional annotation analysis and comparison to the already published SARS-CoV-2 protein interaction map revealed that MXene-treatment exerts specific inhibitory mechanisms. Envisaging future antiviral MXene-based drug nano-formulations and considering the central importance of the immune response to viral infections, the immune impact of MXenes was evaluated on human primary immune cells by flow cytometry and single-cell mass cytometry on 17 distinct immune subpopulations. Moreover, 40 secreted cytokines were analyzed by Luminex technology. MXene immune profiling revealed i) the excellent bio and immune compatibility of the material, as well as the ability of MXene ii) to inhibit monocytes and iii) to reduce the release of pro-inflammatory cytokines, suggesting an anti-inflammatory effect elicited by MXene. We here report a selection of MXenes and viral SARS-CoV-2 genotypes/mutations, a series of the computational, structural and molecular data depicting deeply the SARS-CoV-2 mechanism of inhibition, as well as high dimensional single-cell immune-MXene profiling. Taken together, our results provide a compendium of knowledge for new developments of MXene-based multi-functioning nanosystems as antivirals and immune-modulators. |
format | Online Article Text |
id | pubmed-7969865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79698652021-03-18 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2 Unal, Mehmet Altay Bayrakdar, Fatma Fusco, Laura Besbinar, Omur Shuck, Christopher E. Yalcin, Süleyman Erken, Mine Turktas Ozkul, Aykut Gurcan, Cansu Panatli, Oguzhan Summak, Gokce Yagmur Gokce, Cemile Orecchioni, Marco Gazzi, Arianna Vitale, Flavia Somers, Julia Demir, Emek Yildiz, Serap Suzuk Nazir, Hasan Grivel, Jean-Charles Bedognetti, Davide Crisanti, Andrea Akcali, Kamil Can Gogotsi, Yury Delogu, Lucia Gemma Yilmazer, Açelya Nano Today Article Two-dimensional transition metal carbides/carbonitrides known as MXenes are rapidly growing as multimodal nanoplatforms in biomedicine. Here, taking SARS-CoV-2 as a model, we explored the antiviral properties and immune-profile of a large panel of four highly stable and well-characterized MXenes - Ti(3)C(2)T(x), Ta(4)C(3)T(x), Mo(2)Ti(2)C(3)T(x) and Nb(4)C(3)T(x). To start with antiviral assessment, we first selected and deeply analyzed four different SARS-CoV-2 genotypes, common in most countries and carrying the wild type or mutated spike protein. When inhibition of the viral infection was tested in vitro with four viral clades, Ti(3)C(2)T(x) in particular, was able to significantly reduce infection only in SARS-CoV-2/clade GR infected Vero E6 cells. This difference in the antiviral activity, among the four viral particles tested, highlights the importance of considering the viral genotypes and mutations while testing antiviral activity of potential drugs and nanomaterials. Among the other MXenes tested, Mo(2)Ti(2)C(3)T(x) also showed antiviral properties. Proteomic, functional annotation analysis and comparison to the already published SARS-CoV-2 protein interaction map revealed that MXene-treatment exerts specific inhibitory mechanisms. Envisaging future antiviral MXene-based drug nano-formulations and considering the central importance of the immune response to viral infections, the immune impact of MXenes was evaluated on human primary immune cells by flow cytometry and single-cell mass cytometry on 17 distinct immune subpopulations. Moreover, 40 secreted cytokines were analyzed by Luminex technology. MXene immune profiling revealed i) the excellent bio and immune compatibility of the material, as well as the ability of MXene ii) to inhibit monocytes and iii) to reduce the release of pro-inflammatory cytokines, suggesting an anti-inflammatory effect elicited by MXene. We here report a selection of MXenes and viral SARS-CoV-2 genotypes/mutations, a series of the computational, structural and molecular data depicting deeply the SARS-CoV-2 mechanism of inhibition, as well as high dimensional single-cell immune-MXene profiling. Taken together, our results provide a compendium of knowledge for new developments of MXene-based multi-functioning nanosystems as antivirals and immune-modulators. Elsevier Ltd. 2021-06 2021-03-18 /pmc/articles/PMC7969865/ /pubmed/33753982 http://dx.doi.org/10.1016/j.nantod.2021.101136 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Unal, Mehmet Altay Bayrakdar, Fatma Fusco, Laura Besbinar, Omur Shuck, Christopher E. Yalcin, Süleyman Erken, Mine Turktas Ozkul, Aykut Gurcan, Cansu Panatli, Oguzhan Summak, Gokce Yagmur Gokce, Cemile Orecchioni, Marco Gazzi, Arianna Vitale, Flavia Somers, Julia Demir, Emek Yildiz, Serap Suzuk Nazir, Hasan Grivel, Jean-Charles Bedognetti, Davide Crisanti, Andrea Akcali, Kamil Can Gogotsi, Yury Delogu, Lucia Gemma Yilmazer, Açelya 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2 |
title | 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2 |
title_full | 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2 |
title_fullStr | 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2 |
title_full_unstemmed | 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2 |
title_short | 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2 |
title_sort | 2d mxenes with antiviral and immunomodulatory properties: a pilot study against sars-cov-2 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969865/ https://www.ncbi.nlm.nih.gov/pubmed/33753982 http://dx.doi.org/10.1016/j.nantod.2021.101136 |
work_keys_str_mv | AT unalmehmetaltay 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT bayrakdarfatma 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT fuscolaura 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT besbinaromur 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT shuckchristophere 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT yalcinsuleyman 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT erkenmineturktas 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT ozkulaykut 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT gurcancansu 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT panatlioguzhan 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT summakgokceyagmur 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT gokcecemile 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT orecchionimarco 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT gazziarianna 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT vitaleflavia 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT somersjulia 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT demiremek 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT yildizserapsuzuk 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT nazirhasan 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT griveljeancharles 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT bedognettidavide 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT crisantiandrea 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT akcalikamilcan 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT gogotsiyury 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT deloguluciagemma 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 AT yilmazeracelya 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2 |